HPS1 Knockout A-549 Cell Line
Cat.No.:
EDC90250
Species:
Human
Cell Name:
A-549
Gene:
HPS1
Gene ID:
3257
Size:
1×10⁶cells
HPS1 Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90250 |
|---|---|
| Product Name | HPS1 Knockout A549 Cell Line |
| Cell Line | A-549 |
| Cellosaurus ID | CVCL_0023 |
| Cell Line Synonyms | A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 |
| Gene | HPS1 |
| NCBI Gene ID | |
| Gene Synonyms | BLOC3S1|HPS |
| Summary |
This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
|
| Associated Diseases | Non-Small Cell Lung Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4 ,2days |
| Complete Culture Medium | F-12K + 10% FBS |
| Freezing Medium | 95% Complete culture medium + 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying HPS1 function, HPS1 Knockout A-549 Cell Line or HPS1 overexpression A-549 Cell Line?
The choice depends on whether you are studying HPS1's role as a BLOC-3 complex subunit or modeling Hermansky-Pudlak syndrome type 1 with its characteristic pulmonary fibrosis. The Knockout line is the standard tool for asking whether HPS1 is required for these processes — HPS1 partners with HPS4 to form the BLOC-3 (biogenesis of lysosome-related organelles complex 3), a GEF for Rab32/Rab38 that controls the formation and maturation of lysosome-related organelles (LROs) including melanosomes, platelet dense granules, and lung lamellar bodies. Overexpression is useful for studying HPS1 in heterologous expression contexts.
For pulmonary disease research, the EDITGENE HPS1 Knockout in A-549 is highly relevant — A-549 is an alveolar type II cell-like cancer line, and HPS1 mutations cause Hermansky-Pudlak syndrome type 1 with characteristic pulmonary fibrosis (HPS-related interstitial pneumonia, HPSIP) due to defective alveolar type II cell lamellar body biogenesis and surfactant secretion. Rescue with wild-type or HPS4-binding-deficient HPS1 enables structure-function studies. The knockout is valuable for studying HPS pulmonary fibrosis mechanisms and emerging HPS1-related therapeutic approaches.
What are the application scenarios for this model?
Primary applications:
• BLOC-3 complex assembly: HPS1-HPS4 heterodimer formation and Rab32/Rab38 GEF activity analysis.
• Lung lamellar body biogenesis: in alveolar type II-relevant context, lamellar body morphology and surfactant secretion analysis given A-549's alveolar type II origin.
• HPS pulmonary fibrosis modeling: rescue with patient-derived HPS1 mutations for genotype-function studies of Hermansky-Pudlak syndrome interstitial pneumonia.
• Lysosome-related organelle biology: in melanocyte- or platelet-relevant contexts, LRO biogenesis studies.
EDITGENE recommends this model for researchers investigating HPS1 biology, BLOC-3 complex function, and Hermansky-Pudlak syndrome pulmonary fibrosis mechanisms.
Is this HPS1 Knockout A-549 Cell Line compatible with overexpression rescue experiments?
Yes. HPS1 rescue experiments require attention to BLOC-3 complex assembly:
• Construct design: use a codon-modified HPS1 sequence with a small C-terminal tag (FLAG, HA). HPS1 has N-terminal HPS4-interaction region and C-terminal Rab32/Rab38 GEF region — preserve all elements.
• HPS4-binding-deficient rescue: HPS4-interaction surface mutations disrupt BLOC-3 complex formation.
• HPS mutation rescue: patient-derived HPS1 mutations (e.g., founder Puerto Rican 16-bp duplication) enable disease genotype-function studies.
• Functional readout: rescue should restore lysosome-related organelle biogenesis (in melanocyte/platelet contexts) and surfactant lamellar body formation in alveolar contexts.
A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download